Other lymphoid leukemia, in remission, refers to a group of hematological malignancies characterized by the proliferation of lymphoid cells. This condition is clinically significant as it indicates a state where the disease is not actively progressing, allowing for better management and treatment options. The ICD-10 Code C91.Z1 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.
ICD-10 Code C91.Z1 represents Other lymphoid leukemia, in remission, which encompasses various forms of lymphoid malignancies that have responded to treatment. This code should be used when documenting cases where the patient has achieved remission, indicating no active disease. Accurate coding is essential for clinical documentation, billing, and ensuring appropriate treatment plans are followed.
Other lymphoid leukemia, in remission, is characterized by the presence of abnormal lymphoid cells in the blood or bone marrow, which have responded to treatment. The condition requires ongoing monitoring to ensure that remission is maintained and to prevent relapse.
ICD-10 Code C91.Z1 is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers have a clear understanding of the patient's condition.
In SOAP notes, ICD-10 Code C91.Z1 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Other lymphoid leukemia, in remission, requires a comprehensive approach to maintain remission and monitor for relapse.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C91.Z1 is crucial in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C91.Z1 for Other lymphoid leukemia, in remission
What does it mean if a patient is in remission?
Being in remission means that the signs and symptoms of Other lymphoid leukemia are not currently present, indicating a positive response to treatment. However, ongoing monitoring is essential to detect any potential relapse.
How often should patients in remission be monitored?
Patients in remission should typically have follow-up appointments every 3 to 6 months, depending on their individual risk factors and treatment history, to monitor for any signs of relapse.
Can Other lymphoid leukemia come back after remission?
Yes, Other lymphoid leukemia can relapse after a period of remission. Regular monitoring and follow-up care are crucial to detect any recurrence early.
What are the common treatments for Other lymphoid leukemia?
Treatment options may include chemotherapy, targeted therapy, and supportive care. The specific approach depends on the type of lymphoid leukemia and the patient's overall health.
Clinical Notes
SOAP notes
DAP notes
AI medical notes